Eletriptan Hydrobromide (Technophage)

氢溴酸依立曲坦 (Technophage)

Report date: 2025/05/23 20:00:56

Base Information

Drug NameEletriptan Hydrobromide (Technophage)
Drug Alias NameEletriptan HBrTZ-161
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1b (5-HT1b) receptor agonistsSerotonin 1d (5-HT1d) receptor agonists
TargetsSerotonin 1b (5-HT1b) receptorSerotonin 1d (5-HT1d) receptor
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTechnophage SA
China Registration ClassN/A

Develop Information

Active CompaniesTechnophage SA
Inactive CompaniesN/A
Active IndicationsSpinal Cord Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A